Feature Channels: Infectious Diseases

Filters close
access_time Embargo lifts in 2 days
This news release is embargoed until 3-Apr-2024 8:00 AM EDT Released to reporters: 29-Mar-2024 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Apr-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   

Not for public release

This news release is embargoed until 1-Apr-2024 5:00 PM EDT Released to reporters: 27-Mar-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Cancer therapies show promise in combating tuberculosis
Released: 25-Mar-2024 3:05 PM EDT
Cancer therapies show promise in combating tuberculosis
University of Notre Dame

A study from the University of Notre Dame, Massachusetts General Hospital and the National Institutes of Health has identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery.

Newswise: Breakthrough antibiotic shows promise against obstinate mycobacterial infections
Released: 25-Mar-2024 3:05 AM EDT
Breakthrough antibiotic shows promise against obstinate mycobacterial infections
National University of Singapore (NUS)

A team of scientists led by Prof Guillermo Bazan from NUS Institute for Functional Intelligent Materials (I-FIM) has developed a novel antibiotic named COE-PNH2 that is capable of combating hard-to-treat mycobacterial lung infections.

   
Newswise: New vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies
Released: 21-Mar-2024 3:05 PM EDT
New vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies
University of California, Los Angeles (UCLA), Health Sciences

A vaccine against the bacterium that causes melioidosis was highly protective against the disease, which is endemic in many tropical areas, causing approximately 165,000 cases with 89,000 fatalities around the world each year. It is so dangerous that it is categorized as a Tier 1 Select Agent of bioterrorism.

Released: 21-Mar-2024 10:05 AM EDT
Michigan is seeing a rise in measles: MSU experts can comment on related health issues
Michigan State University

Earlier this week, the Centers for Disease Control and Prevention, or CDC, issued an advisory to inform clinicians and public health officials of an increase in global and U.S. measles cases.

Released: 20-Mar-2024 1:05 PM EDT
Experts warn climate change will fuel spread of infectious diseases
UC Davis Health

Infectious diseases specialists call the medical field to be ready to deal with the impact of climate change on spreading diseases, such as malaria, Valley fever, E-coli and Lyme disease.

Released: 19-Mar-2024 3:05 PM EDT
Targeting multiple COVID variants through the twist in the spike protein
University of Michigan

Teardrop-shaped particles designed to inactivate multiple strains of the SARS-CoV-2 virus could one day complement existing treatments for COVID-19, according to a new study led by researchers at the University of Michigan and Jiangnan University in Wuxi, China.

Released: 18-Mar-2024 11:05 AM EDT
Don’t Delay Vaccines—They Are Safe, Effective and Save Lives
Children's Hospital Los Angeles

Vaccine misinformation has gone mainstream—a post-pandemic reality that is putting more children at risk of exposure to potentially serious vaccine-preventable diseases like measles.

Newswise: Mutations do not predict the severity of current variants of SARS-CoV-2
Released: 15-Mar-2024 12:05 PM EDT
Mutations do not predict the severity of current variants of SARS-CoV-2
University of North Carolina at Charlotte

New research from UNC Charlotte’s Center for Computational Intelligence to Predict Health and Environmental Risks has found that the two most prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.1, are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a high number of mutations compared to previous variants.

Newswise: UCLA Health Taps Dr. Priscilla Hsue as Chief of the Cardiology Division
Released: 14-Mar-2024 2:30 PM EDT
UCLA Health Taps Dr. Priscilla Hsue as Chief of the Cardiology Division
University of California, Los Angeles (UCLA), Health Sciences

The UCLA Department of Medicine is pleased to announce that Priscilla Hsue, MD will be joining us as the chief of the Division of Cardiology at UCLA, effective July 1, 2024.

Released: 14-Mar-2024 1:15 PM EDT
New Tuberculosis Test Could Improve TB Care Globally by Increasing Access to Testing in Low- and Middle-Income Countries
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new tuberculosis (TB) test disclosed in the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) Clinical Chemistry journal would allow testing for TB treatment monitoring to occur outside of a biosafety level 3 (BSL-3) laboratory.

Released: 14-Mar-2024 11:05 AM EDT
Measles 2024: What You Need to Know
RUSH

Measles cases are being reported in different parts of the United States. David Nguyen, MD, a RUSH infectious disease physician who treats adults and children, answers the most common questions about the measles virus.

Newswise: Mount Sinai Establishes Department of Public Health
12-Mar-2024 9:30 AM EDT
Mount Sinai Establishes Department of Public Health
Mount Sinai Health System

Rosalind J. Wright, MD, MPH, appointed inaugural Dean for Public Health and Chair of the new Department of Public Health to spearhead a state-of-the-art curriculum in public health research, education, and practice that will systematically integrate with medicine, population health, global health, neurosciences, environmental medicine, data science and Artificial Intelligence (AI) disciplines.

Not for public release

This news release is embargoed until 4-Mar-2024 5:00 PM EST Released to reporters: 27-Feb-2024 2:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 4-Mar-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 1-Mar-2024 10:05 AM EST
Cleveland Clinic Researchers Uncover How Virus Causes Cancer, Point to Potential Treatment
Cleveland Clinic

Cleveland Clinic researchers have discovered a key mechanism used by Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer. The research points to effective new treatment options for KSHV-associated cancers, including Kaposi’s sarcoma, primary effusion lymphoma, and HHV8-associated multicentric Castleman disease.

Released: 29-Feb-2024 4:05 PM EST
Microbial viruses act as secret drivers of climate change
Ohio State University

In a new study, scientists have discovered that viruses that infect microbes contribute to climate change by playing a key role in cycling methane, a potent greenhouse gas, through the environment.

Released: 28-Feb-2024 11:00 AM EST
Oxford-Harrington Rare Disease Centre to Hold Webinar Entitled Pioneering a Path to Rare Disease Therapeutics
University Hospitals Cleveland Medical Center

The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, U.K. and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, aimed at driving cutting-edge rare disease breakthroughs, is delighted to announce it will be hosting a webinar entitled Pioneering a Path to Rare Disease Therapeutics.

Released: 27-Feb-2024 9:05 PM EST
First DNA study of ancient Eastern Arabians reveals malaria adaptation - study
University of Birmingham

People living in ancient Eastern Arabia appear to have developed resistance to malaria following the appearance of agriculture in the region around five thousand years ago, a new study reveals.

Released: 27-Feb-2024 12:05 PM EST
Dengue: Especialista da Mayo Clinic explica a infecção transmitida por mosquitos
Mayo Clinic

Cerca de metade da população mundial vive em zonas vulneráveis a dengue, uma infecção viral potencialmente fatal transmitida através das picadas de mosquitos infectados. Não há tratamento, e apenas as pessoas que já tiveram dengue são elegíveis para a vacina.

Released: 27-Feb-2024 12:05 PM EST
Dengue: Experta de Mayo Clinic explica la infección transmitida por mosquitos
Mayo Clinic

Aproximadamente la mitad de la población mundial vive en zonas vulnerables a dengue, una infección viral potencialmente mortal transmitida a través de las picaduras de mosquitos infectados. No hay tratamiento, y solo las personas que ya han tenido dengue son elegibles para la vacuna.

Newswise: UT Southwestern finds genetic clues to complex infections
Released: 26-Feb-2024 10:05 AM EST
UT Southwestern finds genetic clues to complex infections
UT Southwestern Medical Center

Treating complex bacterial infections with customized therapies tailored to the infection and the patient is closer to reality, thanks to researchers at UT Southwestern Medical Center.

Newswise:Video Embedded measles-makes-a-comeback-what-parents-need-to-know
VIDEO
Released: 23-Feb-2024 2:05 PM EST
Measles Makes a Comeback: What Parents Need to Know
Cedars-Sinai

A highly contagious childhood disease once eradicated by vaccination has made a comeback.

Newswise: Wistar Scientists Discover Link Between Leaky Gut and 
Accelerated Biological Aging
Released: 23-Feb-2024 10:05 AM EST
Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging
Wistar Institute

Wistar Institute’s Dr. Mohamed Abdel-Mohsen has demonstrated a connection between viral damage to the gut and premature biological aging.

Released: 22-Feb-2024 3:05 PM EST
Study finds high number of persistent COVID-19 infections in the general population
University of Oxford

A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.

Newswise: Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds
20-Feb-2024 12:05 PM EST
Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds
University of California, Los Angeles (UCLA), Health Sciences

A UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and automated text messages more than doubled the use of the HIV prevention strategy, called PrEP, among younger, at-risk Americans, a group that historically has had low use of the medication.

Released: 21-Feb-2024 2:05 PM EST
Study examines medical mystery of child hepatitis outbreak
University of Sydney

A world-first analysis of a sudden global outbreak of hepatitis in children finds although the primary suspect is highly likely to be an infection by multiple viruses, many questions still puzzle researchers.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 20-Feb-2024 10:05 AM EST
Association for Molecular Pathology Releases Survey Findings and Recommendations to Improve Implementation of European Union’s In Vitro Diagnostic Regulation
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the results of its Impacts of the European Union (EU) In Vitro Diagnostic Regulation (IVDR) Survey. The anonymous survey was created and administered to molecular diagnostics professionals around the world to determine current levels of understanding, assess broad implications, and identify future trends related to the new regulation.

Released: 19-Feb-2024 8:05 PM EST
Studies find flu vaccines were effective in 2022-2023 flu season
Regenstrief Institute

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines.

19-Feb-2024 5:00 AM EST
Droughts may trigger HIV transmission increase among women in rural sub-Saharan Africa, study finds
University of Bristol

Droughts have the potential to increase the spread of HIV for women living in rural parts of Africa, researchers at the University of Bristol have found.

Released: 15-Feb-2024 2:00 PM EST
UIC research helps create new antibiotic that evades bacterial resistance
University of Illinois Chicago

New drug inspired by images that captured how bacteria block antibiotic activity

   
Newswise:Video Embedded magnetic-fields-kill-bacteria-that-infect-medical-implants
VIDEO
Released: 15-Feb-2024 10:05 AM EST
Magnetic fields kill bacteria that infect medical implants
UT Southwestern Medical Center

The same technology at work in induction cooktops cut the amount of bacteria present in a prosthetic joint infection when used in conjunction with antibiotics in a mouse model, UT Southwestern Medical Center researchers report in a new study.

13-Feb-2024 2:05 PM EST
Study Reveals Accelerated Aging in Women Living With HIV
Rutgers University-New Brunswick

Women with HIV experience accelerated DNA aging, a phenomenon that can lead to poor physical function, according to a study led by Stephanie Shiau, an assistant professor in the Department of Biostatistics and Epidemiology at the Rutgers School of Public Health.

Newswise: Scientists discover hidden army of lung flu fighters
Released: 14-Feb-2024 11:05 PM EST
Scientists discover hidden army of lung flu fighters
University of California, Riverside

Scientists have long thought of the fluid-filled sac around our lungs merely as a cushion from external damage.

Newswise: Johns Hopkins Medicine-Led Study Shows Rapid COVID-19 Tests Done at Home are Reliable
Released: 13-Feb-2024 11:00 PM EST
Johns Hopkins Medicine-Led Study Shows Rapid COVID-19 Tests Done at Home are Reliable
Johns Hopkins Medicine

In a study involving nearly 1,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a five-month period in 2022 — researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine and five other collaborators report that a rapid antigen test (RAT) for detecting SARS-CoV-2, the virus that causes COVID-19, can be used at home with accuracy comparable to the same test being administered by a health care professional.



close
3.3826